Glatiramer acetate vs placebo
Patients who progressed ‐ at 2 years · people with multiple sclerosis
Glatiramer acetate showed no clear difference in patients who progressed ‐ at 35 months compared with placebo; GRADE not reported.
1 finding from 1 review
- RR 0.81 [0.5, 1.29]1 study · 203 participantsGRADE not reported